TCL Archive Panel Recommends Against Pooling Results Of NLST, European Studies, And I-ELCAP. NIH Director Zerhouni To Step Down At End Of October; Six-Year Tenure Brought Many Changes To NIH. September 26, 2008
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures February 22, 1974
TCL Archive Ethics Commission Remains Split On Compensation But Tells To Develop Pilot Program Proposal May 15, 1981
